Keywords: biota, benefits, flu, vacc, shortage, potential, crucial

Biota benefits from flu vacc shortage

Article | 22 November 2004

Print This

A potential shortage of crucial flu vaccines in the USA has boosted Australian biotechnology company Biota. Chiron, which had been ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in